CDG Petchem (534796)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

When I look at CDG Petchem, I am reminded of Graham's rule: 'Price is what you pay; value is what you get.' The market cap is just ₹7 crore, and the latest quarter shows sales of ₹22 crore and net profit of ₹3 crore. At face value, that sounds interesting, but the P/E of 206.17 and P/B of 296.50 tell me the earning base is tiny and the book value is razor-thin at ₹0.08 per share. With ROE at -208.47% and ROCE at -5.10%, this business is destroying capital, not creating it. Sales growth of 306.97% and profit growth of 1000% may excite traders, but growth on a negative return on equity usually consumes more cash than it generates. The 52-week range of ₹55.23 to ₹222.20, with the stock now at ₹23.72, shows Mr. Market has already rendered a harsh verdict. There is no dividend to compensate me while I wait, and debt/equity and promoter holding data are unavailable—two red flags for disclosure. The Piotroski F-Score of 6 suggests some improvement, and a PEG of 0.32 looks cheap, but PEG is meaningless when the P/E is built on unsustainable or low-quality earnings. This is a tiny, volatile, and financially weak company. I need a margin of safety; I do not see one here. This goes into the 'too hard' pile.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer